NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma

Name: NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma
Published: 2021
License: Public Domain

Xennials Therapeutics Australia Pty Ltd · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

gradeglioma platinum resistant

advanced solid tumor, platinum-resistant ovarian cancer, platinum-resistant urothelial carcinoma, high-grade glioma, hypomethylating agent, nucleoside analog, dna demethylation, solid tumors, ovarian neoplasms, urinary bladder neoplasms, platinum-resistant, carboplatin

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 826309
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.